generic drug price fixing Archives - Corruption, Crime & Compliance

28 Jul, 2020

DOJ Criminal Generic Pharma Price-Fixing Investigation Gathers Steam: Taro Pharmaceuticals Agrees to Pay DOJ Total of $419 Million

The DOJ Antitrust Division’s multi-year criminal cartel investigation of the generic pharmaceutical industry is gaining steam. The latest company to settle is Taro Pharmaceuticals which agreed to enter a deferred prosecution agreement and pay a $205.7 million penalty to resolve charges relating to a criminal price-fixing conspiracy. The Antitrust Division’s settlement with Taro is the 10th case, and the 6th company to be charged or...

General

9 Mar, 2020

DOJ Catches Big Fish in Generic Pharmaceutical Criminal Antitrust Investigation

The Justice Department’s Antitrust Division announced a major guilty plea with Sandoz, Inc., in its expanding criminal investigation of the generic pharmaceutical industry. DOJ has been pursuing this investigation for several years with some progress, but the Sandoz guilty plea is a major accomplishment in the investigation. Sandoz agreed to pay $195 million in exchange for a three-year deferred purchase agreement (“DPA”). DOJ filed a...